Eisai Inc - Strategic SWOT Analysis Review

GlobalData
35 Pages - GLDATA60793
$125.00

Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi's sarcoma. The company’s research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc Key Recent Developments

Dec 01, 2016: Rebecca Jolley appointed Senior Vice President Americas Commercial, Oncology Business Group at Eisai
Sep 15, 2016: Eisai Establishes AiM Institute to Discover Human Biology Driven Precision Medicines
Jun 29, 2016: Eisai Highlights its Strong Pipeline and Innovative Approach to R&D at Company's U.S. Scientific Day
May 24, 2016: Maria Garrigan appointed Vice President, Global Regulatory Strategy, Oncology Business Group at Eisai
Apr 20, 2016: Dr. Avinash Desai appointed Vice President, Americas Oncology Medical Affairs, Oncology Business Group at Eisai

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Section 1 - About the Company 5
Eisai Inc - Key Facts 5
Eisai Inc - Key Employees 6
Eisai Inc - Key Employee Biographies 7
Eisai Inc - Major Products and Services 8
Eisai Inc - History 9
Eisai Inc - Company Statement 13
Eisai Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Eisai Inc - Business Description 15
Eisai Inc - Corporate Strategy 16
Eisai Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Eisai Inc - Strengths 17
Eisai Inc - Weaknesses 18
Eisai Inc - Opportunities 19
Eisai Inc - Threats 20
Eisai Inc - Key Competitors 21
Section 3 – Company’s Lifesciences Financial Deals and Alliances 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Eisai Inc, Recent Deals Summary 24
Section 4 – Company’s Recent Developments 25
Dec 01, 2016: Rebecca Jolley appointed Senior Vice President Americas Commercial, Oncology Business Group at Eisai 25
Sep 15, 2016: Eisai Establishes AiM Institute to Discover Human Biology Driven Precision Medicines 26
Jun 29, 2016: Eisai Highlights its Strong Pipeline and Innovative Approach to R&D at Company's U.S. Scientific Day 28
May 24, 2016: Maria Garrigan appointed Vice President, Global Regulatory Strategy, Oncology Business Group at Eisai 29
Apr 20, 2016: Dr. Avinash Desai appointed Vice President, Americas Oncology Medical Affairs, Oncology Business Group at Eisai 30
Apr 11, 2016: Beyhan Zaim appointed Vice President Commercial Development & Alzheimer's Disease Global Lead, Neurology Business Group at Eisai 31
Apr 06, 2016: Paul Hawthorne appointed Senior Vice President, U.S. Commercial, Neurology Business Group at Eisai 32
Mar 30, 2016: Global Drug Maker Eisai Signs Three-Year Contract Extension For CSC’s Total Regulatory Solution as-a-Service 33
Feb 16, 2016: Dementia Consortium signs new pharmaceutical partner AbbVie 34
Section 5 – Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Eisai Inc, Key Facts 5
Eisai Inc, Key Employees 6
Eisai Inc, Key Employee Biographies 7
Eisai Inc, Major Products and Services 8
Eisai Inc, History 9
Eisai Inc, Other Locations 14
Eisai Inc, Subsidiaries 14
Eisai Inc, Key Competitors 21
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 23
Eisai Inc, Recent Deals Summary 24

List of Figures
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 22
Eisai Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 23

$125.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838